
trans-o-flex grows by almost five per cent in the first half of the year

You are currently viewing a placeholder content from Facebook. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from Instagram. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from X. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More Information
With a 4.6 per cent increase in turnover to 264 million euros, trans-o-flex grew significantly in the first half of 2021 compared to the same period last year, despite the coronavirus pandemic. The trans-o-flex ThermoMed business unit achieved the strongest growth with almost ten per cent. “This shows impressively that we are continuing to grow,” said Wolfgang P. Albeck, CEO of trans-o-flex. “The pandemic, in particular, shows us how important fast, safe and reliable logistics are in the pharmaceutical sector. As the German market leader for the active temperature-controlled transport of medicines and an expert in express special logistics, we are particularly in demand as a reliable partner for our customers.” More information on our first half of 2021 in our press release > https://www.trans-o-flex.com/en/press/trans-o-flex-shows-robust-profitable-growth-in-h1-2021/